Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Cerebrospinal Fluid Shunt Survival and Etiology of Failures: A Seven-Year Institutional Experience

McGirt M.J. · Leveque J.-C. · Wellons III J.C. · Villavicencio A.T. · Hopkins J.S. · Fuchs H.E. · George T.M.

Author affiliations

Pediatric Neurosurgery Service, Division of Neurosurgery, Duke University Medical Center, Durham, N.C., USA

Related Articles for ""

Pediatr Neurosurg 2002;36:248–255

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: May 30, 2002
Issue release date: May 2002

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 4

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE

Abstract

Background: Innovations in shunt technology and neuroendoscopy have been increasingly applied to shunt management. However, the relative life span of shunts and the etiology of shunt failure have not been characterized recently. Methods: We reviewed the records of all shunting procedures at our institution between January 1992 and December 1998. Independent predictors of shunt failure were analyzed via multivariate Cox regression analysis in 836 shunting procedures. Independent predictors of the etiology of failure (infection, proximal obstruction, distal malfunction) were analyzed via multivariate logistic regression analysis in the 383 shunts which failed. Results: A total of 353 pediatric patients underwent 308 shunt placements and 528 revisions. The risk (hazard ratio; HR) of shunt failure decreased as a function of time in both primary placements and revised shunts. In failed shunts, the odds of infection decreased 4-fold per year of shunt function, while the odds of distal malfunction increased 1.45-fold per year. Increasing number of shunt revisions (HR 1.31, p < 0.05), decreasing patient age in years (HR 1.04, p < 0.001), gestational age <40 weeks (HR 2.15, p < 0.001) but not the etiology of hydrocephalus were associated with an increased risk of shunt failure. Revisions versus primary placements, Dandy-Walker cysts and gestational age <40 weeks were independently associated with proximal, distal and infectious causes of failure, respectively. Conclusions: The long-term shunt revision rates observed here are similar to those reported over the past 2 decades. Shunt life span remains poorer in shunt revisions and in younger patients. Patient characteristics may suggest a specific risk and mechanism of failure, aiding in the long-term management of shunted hydrocephalus.

© 2002 S. Karger AG, Basel


References

  1. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: A prospective study of risk factors. J Neurosurg 2001;94:195–201.
  2. Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995;23:254–258.
  3. Nulsen FE, Spitz EB: Treatment of hydrocephalus by direct shunt from ventricle to jugular vein. Surg Forum 1952;2:399–403.
  4. Ignelzi RJ, Kirsch WM: Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus. J Neurosurg 1975;42:679–682.
  5. Keucher TR, Mealey J Jr: Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus. J Neurosurg 1979;50:179–186.
  6. Little JR, Rhoton AL Jr, Mellinger JF: Comparison of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus in children. Mayo Clin Proc 1972;47:396–401.
    External Resources
  7. Olsen L, Frykberg T: Complications in the treatment of hydrocephalus in children. A comparison of ventriculoatrial and ventriculoperitoneal shunts in a 20-year material. Acta Paediatr Scand 1983;72:385–390.
  8. Albright AL, Haines SJ, Taylor FH: Function of parietal and frontal shunts in childhood hydrocephalus. J Neurosurg 1988;69:883–886.
  9. Griebel R, Khan M, Tan L: CSF shunt complications: An analysis of contributory factors. Childs Nerv Syst 1985;1:77–80.
    External Resources
  10. Liptak GS, McDonald JV: Ventriculoperitoneal shunts in children: Factors affecting shunt survival. Pediatr Neurosci 1985;12:289–293.
    External Resources
  11. Piatt JH Jr, Carlson CV: A search for determinants of cerebrospinal fluid shunt survival: Retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg 1993;19:233–242.
  12. Sainte-Rose C, Piatt JH, Renier D, Pierre-Kahn A, Hirsch JF, Hoffman HJ, Humphreys RP, Hendrick EB: Mechanical complications in shunts. Pediatr Neurosurg 1991;17:2–9.
  13. Serlo W, von Wendt L, Heikkinen ES, Heikkinen ER: Ball and spring or slit and core valve for hydrocephalus shunting? Ann Clin Res 1986;18(suppl 47):103–106.
  14. Robertson JS, Maraqa MI, Jennett B: Ventriculoperitoneal shunting for hydrocephalus. Br Med J 1973;ii:289–292.
  15. Piatt JH Jr: Cerebrospinal fluid shunt failure: Late is different from early. Pediatr Neurosurg 1995;23:133–139.
  16. Punt DW, Jaspan T, Worthington B: Neuroendoscopy in the management of hydrocephalus. Eur J Pediatr Surg 1995;5:39–45.
  17. Kellnar S, Boehm R, Ring E: Ventriculoscopy-aided implantation of ventricular shunts in patients with hydrocephalus. J Pediatr Surg 1995;30:1450–1451.
  18. Pattisapu J, Trumble E, Taylor K, Howard D, Kovach T, Klempen N: Percutaneous endoscopic recanalization of catheter. Eur J Pediatr Surg 2000;10(suppl 1):46–47.
  19. D’Angelo V, Gorgoglione L, Catapano G: Treatment of symptomatic intracranial arachnoid cysts by stereotactic cyst-ventricular shunting. Stereotact Funct Neurosurg 1999;72:62–69.
  20. Lewis AI, Keiper GL Jr, Crone KR: Endoscopic treatment of loculated hydrocephalus. J Neurosurg 1995;82:780–785.
  21. Pang D, Grabb PA: Accurate placement of coronal ventricular catheter using stereotactic coordinate-guided free-hand passage. Technical note. J Neurosurg 1994;80:750–755.
  22. Lazareff JA, Peacock W, Holly L, Ver Halen J, Wong A, Olmstead C: Multiple shunt failures: An analysis of relevant factors. Childs Nerv Syst 1998;14:271–275.
  23. Therneau T: Extending the Cox model; in Lin DY, Fleming TR (eds): Proceedings of the First Seattle Symposium in Biostatistics. New York, Springer, 1997, pp 21–35.
  24. Prentice R, Williams B, Peterson A: On the regression analysis of multivariate failure time data. Biometrika 1981;68:373–379.
  25. Cleves M: Analysis of multiple failure-time survival data. Stata Technical Bulletin STB-49, http:/www.stata.com/support/faqs/stat/stmfail.html, 1999.
  26. Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M: Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000;92:31–38.
  27. Stata Corporation: Stata Statistics/Data Analysis Software for Windows©, version 7.0. College Station, Stata Corporation, 1984–2001.
  28. SAS Institute: Windows TSSf©, version 8.2. Cary, SAS Institute, 1999–2001.
  29. Albright AL, Pollack IF, Adelson PD, Solot JJ: Outcome data and analysis in pediatric neurosurgery. Neurosurgery 1999;45:101–106.
  30. Iskandar BJ, Tubbs S, Mapstone TB, Grabb PA, Bartolucci AA, Oakes WJ: Death in shunted hydrocephalic children in the 1990s. Pediatr Neurosurg 1998;28:173–176.
  31. Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N: Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998;43:294–305.
  32. Di Rocco C, Marchese E, Velardi F: A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991–1992 Education Committee of the ISPN. Childs Nerv Syst 1994;10:321–327.
  33. Pollack IF, Albright AL, Adelson PD: A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery 1999;45:1399–1411.
  34. Liptak GS, Masiulis BS, McDonald JV: Ventricular shunt survival in children with neural tube defects. Acta Neurochir (Wien) 1985;74:113–117.
  35. James HE, Bejar R, Gluck L, Coen R, Merritt A, Mannino F, Bromberger P, Saunders B, Schneider H: Ventriculoperitoneal shunts in high risk newborns weighing under 2000 grams: A clinical report. Neurosurgery 1984;15:198–202.
    External Resources
  36. Meirovitch J, Kitai-Cohen Y, Keren G, Fiendler G, Rubinstein E: Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1987;6:921–924.
    External Resources
  37. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: A study of etiological factors. J Neurosurg 1992;77:29–36.
  38. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch JF: Factors causing acute shunt infection. Computer analysis of 1174 operations. J Neurosurg 1984;61:1072–1078.
    External Resources
  39. Hahn YS: Use of the distal double-slit valve system in children with hydrocephalus. Childs Nerv Syst 1994;10:99–103.
  40. Cozzens JW, Chandler JP: Increased risk of distal ventriculoperitoneal shunt obstruction associated with slit valves or distal slits in the peritoneal catheter. J Neurosurg 1997;87:682–686.
  41. Choudhury AR: Avoidable factors that contribute to the complications of ventriculoperitoneal shunt in childhood hydrocephalus. Childs Nerv Syst 1990;6:346–349.
  42. Rekate HL: Shunt revision: Complications and their prevention. Pediatr Neurosurg 1991;17:155–162.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: May 30, 2002
Issue release date: May 2002

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 4

ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)

For additional information: https://www.karger.com/PNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.